M28 Capital Management LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
M28 Capital Management LP disclosed 11 US equity positions worth $91.0m in its Q3 2024 13F filing. The largest position was WVE at 55.5% of the reported book, followed by IVVD and RCKT.
What did M28 Capital Management LP own in Q3 2024? Top 11 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 55.5% | $50.5m | 6,164,548 | – | |
| 2 | IVVD INVIVYD INC | Healthcare | 10.4% | $9.4m | 9,248,250 | – | |
| 3 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 7.8% | $7.1m | 385,680 | – | |
| 4 | GUTS FRACTYL HEALTH INC | 5.2% | $4.7m | 1,856,117 | – | ||
| 5 | TGTX TG THERAPEUTICS INC | Healthcare | 4.2% | $3.8m | 161,600 | – | |
| 6 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 3.9% | $3.5m | 110,400 | – | ||
| 7 | SLN SILENCE THERAPEUTICS PLC | 3.7% | $3.4m | 185,100 | – | ||
| 8 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.4% | $3.1m | 121,200 | – | |
| 9 | CRIS CURIS INC | 2.5% | $2.3m | 421,951 | – | ||
| 10 | PROQR THRAPEUTICS N V | 2.0% | $1.9m | 1,019,498 | – | ||
| 11 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.4% | $1.3m | 67,400 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.